Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial

Overview of attention for article published in European Urology Oncology, July 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 15 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 17 X posts from 15 X users, with an upper bound of 126,580 followers.

RT @montypal: Congrats @TiansterZhang & team on this terrific paper in @EurUrolOncol examining #docetaxel, #apalutamide & #radiotherapy in…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 13 additional X posts.